RALLYBIO CORPORATION Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
RALLYBIO CORPORATION (RLYB) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $700.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2022-11-07
- RALLYBIO CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-03-31 was $700.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month |
|---|---|---|
| 2022-03-31 | $700.00K 10-Q · filed 2022-05-10 | |
| 2022-01-01 | $700.00K 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |